𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Prostate-specific antigen and prostate-specific antigen derivatives as predictors of benign prostatic hyperplasia progression

✍ Scribed by Jonathan M. Levitt; Kevin M. Slawin

Book ID
107555125
Publisher
Springer
Year
2007
Tongue
English
Weight
154 KB
Volume
8
Category
Article
ISSN
1527-2737

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Tissue concentrations of prostate-specif
Tissue concentrations of prostate-specific antigen in prostatic carcinoma and benign prostatic hyperplasia
✍ Thomas G. Pretlow; Theresa P. Pretlow; Bin Yang; Charlotte S. Kaetzel; Carrie M. πŸ“‚ Article πŸ“… 1991 πŸ› John Wiley and Sons 🌐 French βš– 775 KB

## Abstract Prostate‐specific antigen (PSA), as measured in peripheral blood, is currently the most widely used marker for the assessment of tumor burden in the longitudinal study of patients with carcinoma of the prostate (PCA). Studies from other laboratories have led to the conclusion that a giv

Impact of age, benign prostatic hyperpla
Impact of age, benign prostatic hyperplasia, and cancer on prostate-specific antigen level
✍ Rinaa S. Punglia; Anthony V. D'Amico; William J. Catalona; Kimberly A. Roehl; Ka πŸ“‚ Article πŸ“… 2006 πŸ› John Wiley and Sons 🌐 English βš– 195 KB πŸ‘ 2 views

## Abstract ## BACKGROUND The distribution of prostate‐specific antigen (PSA) values for men with or without prostate carcinoma are confounded because of verification bias. Correcting for verification bias, the means and variances of PSA values were estimated in specific clinical scenarios. ## ME